(Q39357705)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Nora Bengoa-Vergniory

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Robert Kypta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

R Siobhan Darrington

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Marjorie M Walker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Irantzu Gorrono-Etxebarria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Pinar Uysal-Onganer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Yoshiaki Kawano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Jonathan Waxman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

language of work or name

English

0 references

publication date

22 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

30 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

E872-83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

GSK-3: Functional Insights from Cell Biology and Animal Models

30 January 2020

cites work

1 reference

Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3

21 January 2018

1 reference

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer

21 January 2018

1 reference

Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma

21 January 2018

1 reference

Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy

21 January 2018

1 reference

Deregulated GSK3beta activity in colorectal cancer: its association with tumor cell survival and proliferation.

21 January 2018

1 reference

Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation

21 January 2018

1 reference

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

21 January 2018

1 reference

Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer

21 January 2018

1 reference

Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth

21 January 2018

1 reference

Inhibition of glycogen synthase kinase-3 in androgen-responsive prostate cancer cell lines: are GSK inhibitors therapeutically useful?

21 January 2018

1 reference

Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.

21 January 2018

1 reference

Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer

21 January 2018

1 reference

Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death

21 January 2018

1 reference

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.

21 January 2018

1 reference

Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development

21 January 2018

1 reference

Distinct molecular regulation of glycogen synthase kinase-3alpha isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling

21 January 2018

1 reference

Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain

21 January 2018

1 reference

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity

21 January 2018

1 reference

Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells

21 January 2018

1 reference

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

21 January 2018

1 reference

Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling

21 January 2018

1 reference

Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation

21 January 2018

1 reference

Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells

21 January 2018

1 reference

The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth.

21 January 2018

1 reference

Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes

21 January 2018

1 reference

C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction

21 January 2018

1 reference

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators

21 January 2018

1 reference

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

21 January 2018

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer

21 January 2018

1 reference

Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells

21 January 2018

1 reference

Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements.

21 January 2018

1 reference

GSK-3: tricks of the trade for a multi-tasking kinase

21 January 2018

1 reference

Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats

21 January 2018

1 reference

The selectivity of protein kinase inhibitors: a further update

21 January 2018

1 reference

Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically

21 January 2018

1 reference

5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors

21 January 2018

1 reference

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

21 January 2018

1 reference

GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death

21 January 2018

1 reference

Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis

21 January 2018

1 reference

Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization

21 January 2018

1 reference

Specific involvement of glycogen synthase kinase-3 in the function and activity of sex steroid hormone receptors reveals the complexity of their regulation

21 January 2018

1 reference

GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json

release_qyqo5eiiujhlfal2k46pnphqme

30 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qyqo5eiiujhlfal2k46pnphqme

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22539113%20AND%20SRC:MED&resulttype=core&format=json